News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuvilex Announces Substantial Development in Pancreatic Cancer Research



7/17/2012 9:19:05 AM

SILVER SPRING, Md., July 17, 2012 (GLOBE NEWSWIRE) -- Nuvilex, Inc. (OTCQB:NVLX), a biotechnology provider of cell and gene therapy solutions, announced today a significant new development in pancreatic cancer research. Pancreatic tumor models in animals have not existed previously that accurately mimic human pancreatic cancer. This research advancement, accomplished by the Nuvilex subsidiary, Austrianova Singapore and their colleagues was just published in the journal PLoS One.

Read at GlobeNewswire


comments powered by Disqus
Nuvilex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES